Apple cider vinegar has been a fixture of folk medicine for centuries, and unlike many home remedies that quietly fade from favor, it has only grown more popular. That staying power alone warrants a closer look.
Vinegar — from the French vin aigre, "sour wine" — is produced through a two-stage fermentation process. First, yeast converts the natural sugars in a carbohydrate source, in this case apples, into alcohol. Acetic acid bacteria then convert that alcohol into acetic acid, the compound responsible for vinegar's sharp bite and most of the benefits attributed to ACV. Most commercial products contain between 4 and 5% acetic acid — a modest concentration, though not a trivial one. Even at these levels, acetic acid is caustic enough to cause real harm if misused.
Vinegar's medicinal reputation is ancient. Hippocrates prescribed it for wound care, and a Chinese physician — reportedly using it as a hand rinse to prevent infection — was practicing something remarkably close to antiseptic technique centuries before Western medicine accepted germ theory at all. Early American healers reached for vinegar to treat poison ivy, croup, stomach ailments, fever, and edema, then commonly called "dropsy." The remedy seemed good for nearly everything.
That tradition of vinegar-as-panacea carries forward into the ACV boom of the present day.
Countless articles and videos extol the many virtues of ACV — but how many of these claims are scientifically plausible?
Acetic acid isn't ACV's only active constituent. Unfiltered, unpasteurized varieties also contain what's known as "the Mother" — a murky, gelatinous web of bacteria and yeast left over from fermentation. It's the reason raw ACV looks cloudy rather than clear, and many advocates consider it the most valuable part of the product. The Mother is a source of polyphenol antioxidants and trace minerals, and some researchers believe its probiotic properties may contribute to ACV's reported benefits in ways that acetic acid alone cannot account for.
The research on ACV carries the usual caveats — small sample sizes, short intervention periods, questions of bias — though those limitations are hardly unique to this corner of nutrition science. What the studies do establish, with reasonable consistency, is a meaningful effect on blood glucose and insulin response.
That finding has taken on new relevance in the age of GLP-1 agonist drugs like Ozempic. ACV appears to work through some of the same mechanisms: it slows gastric emptying, blunts the insulin spike that follows a high-carbohydrate meal, and improves . . .
Join today and get access to this article and all past and present Newsletters, since September 2014. Each month you’ll get a new issue sent to your inbox. Subscribe today for only $10/month!